Detroit CSI: Collaboration to Improve Outcomes in Cardiogenic Shock

February 16, 2017

Announced Wednesday, the Detroit Cardiogenic Shock Initiative (CSI) is an innovative collaboration between five hospital systems in metro Detroit with the goal of determining whether outcomes in cardiogenic shock can be improved by using Impella® as early as possible for patients in the shock spiral.

View the Full Story Here



Led by Dr. Bill O’Neill of Henry Ford Health System, the initiative includes physicians from Henry Ford, Beaumont, Detroit Medical Center Heart Hospital, St. Joseph Mercy Health System and St. John Providence Ascension.

Henry Ford Twitter



Partnering hospital systems use a defined protocol for early placement of Impella in patients in cardiogenic shock. Since July, initial results from a small sampling of 30 patients show survival rates have improved from 50% to 80%.

Dr. O’Neill will present these findings at the American College of Cardiology’s Annual Scientific Session in Washington, DC in March. ProtectedPCI.com will be covering sessions throughout ACC.17 so stay tuned.

Watch The News Story Here


Learn More:

Cardiogenic Shock Protocol
Download Here

Hear From Dr. O’Neill on Impella heart pump
View Here

 

Clinical Dossier Cardiogenic Shock
Download Here

General Indication and Safety Information

To learn more about the Impella platform of heart pumps, including important risk and safety information associated with the use of the devices, please visit: www.protectedpci.com/hcp/information/isi and www.cardiogenicshock.com/information/isi